No photo of silvia michieletto

View Scopus Profile

silvia michieletto

  • 174 Citations
  • 6 h-Index
20072018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where silvia michieletto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Esophagectomy Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2018

  • 174 Citations
  • 6 h-Index
  • 17 Article

Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary

Giarratano, T., Miglietta, F., Giorgi, C. A., Tsvetkova, V., Michieletto, S., Evangelista, L., Polico, I., Dieci, M. V. & Guarneri, V., Dec 3 2018, In : Frontiers in Oncology. 8, p. 581

Research output: Contribution to journal › Article

Skin Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Skin
Therapeutics

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

Dieci, M. V., Guarneri, V., Giarratano, T., Mion, M., Tortora, G., De Rossi, C., Gori, S., Oliani, C., Merlini, L., Pasini, F., Bonciarelli, G., Griguolo, G., Orvieto, E., Michieletto, S., Saibene, T., Del Bianco, P., De Salvo, G. L. & Conte, P., Mar 2018, In : Oncologist. 23, 3, p. 297-305 9 p.

Research output: Contribution to journal › Article

Multicenter Studies
Breast Neoplasms
Recurrence
Genes
Therapeutics
2 Citations (Scopus)

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

Dieci, M. V., Guarneri, V., Giarratano, T., Mion, M., Tortora, G., De Rossi, C., Gori, S., Oliani, C., Merlini, L., Pasini, F., Bonciarelli, G., Griguolo, G., Orvieto, E., Michieletto, S., Saibene, T., Del Bianco, P., De Salvo, G. L. & Conte, P., Nov 13 2017, In : The oncologist.

Research output: Contribution to journal › Article

Multicenter Studies
Breast Neoplasms
Recurrence
Genes
Drug Therapy
6 Citations (Scopus)

A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours

Beffagna, G., Sacchetto, R., Cavicchioli, L., Sammarco, A., Mainenti, M., Ferro, S., Trez, D., Zulpo, M., Michieletto, S., Cecchinato, A., Goldschmidt, M. & Zappulli, V., Jan 1 2016, In : Veterinary Journal. 207, p. 105-111 7 p.

Research output: Contribution to journal › Article

mammary neoplasms (animal)
Felidae
Canidae
cats
Breast Neoplasms
4 Citations (Scopus)

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

Evangelista, L., Cervino, A. R., Ghiotto, C., Saibene, T., Michieletto, S., Fernando, B., Orvieto, E., Guarneri, V. & Conte, P., May 31 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, 11, p. 1648-1655 8 p.

Research output: Contribution to journal › Article

Neoadjuvant Therapy
Glycolysis
Tumor Burden
Breast Neoplasms
Survival